Aberrant localization of signaling proteins in skin cancer

Implications for treatment

Thomas R. Holmes, Shravya Dindu, Laura A. Hansen

Research output: Contribution to journalArticle

Abstract

Aberrant subcellular localization of signaling proteins can provide cancer cells with advantages such as resistance to apoptotic cell death, increased invasiveness and more rapid proliferation. Nuclear to cytoplasmic shifts in tumor-promoting proteins can lead to worse patient outcomes, providing opportunities to target cancer-specific processes. Herein, we review the significance of dysregulated protein localization with a focus on skin cancer. Altered localization of signaling proteins controlling cell cycle progression or cell death is a common feature of cancer. In some instances, aberrant subcellular localization results in an acquired prosurvival function. Taking advantage of this knowledge reveals novel targets useful in the development of cancer therapeutics.

Original languageEnglish (US)
Pages (from-to)1631-1639
Number of pages9
JournalMolecular Carcinogenesis
Volume58
Issue number9
DOIs
StatePublished - Jan 1 2019

Fingerprint

Karyopherins
Skin Neoplasms
Neoplasms
Proteins
Cell Death
Therapeutics
Cell Cycle Proteins

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cancer Research

Cite this

Aberrant localization of signaling proteins in skin cancer : Implications for treatment. / Holmes, Thomas R.; Dindu, Shravya; Hansen, Laura A.

In: Molecular Carcinogenesis, Vol. 58, No. 9, 01.01.2019, p. 1631-1639.

Research output: Contribution to journalArticle

@article{7db81009870e415a8e12cbf3827ca054,
title = "Aberrant localization of signaling proteins in skin cancer: Implications for treatment",
abstract = "Aberrant subcellular localization of signaling proteins can provide cancer cells with advantages such as resistance to apoptotic cell death, increased invasiveness and more rapid proliferation. Nuclear to cytoplasmic shifts in tumor-promoting proteins can lead to worse patient outcomes, providing opportunities to target cancer-specific processes. Herein, we review the significance of dysregulated protein localization with a focus on skin cancer. Altered localization of signaling proteins controlling cell cycle progression or cell death is a common feature of cancer. In some instances, aberrant subcellular localization results in an acquired prosurvival function. Taking advantage of this knowledge reveals novel targets useful in the development of cancer therapeutics.",
author = "Holmes, {Thomas R.} and Shravya Dindu and Hansen, {Laura A.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/mc.23036",
language = "English (US)",
volume = "58",
pages = "1631--1639",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Aberrant localization of signaling proteins in skin cancer

T2 - Implications for treatment

AU - Holmes, Thomas R.

AU - Dindu, Shravya

AU - Hansen, Laura A.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Aberrant subcellular localization of signaling proteins can provide cancer cells with advantages such as resistance to apoptotic cell death, increased invasiveness and more rapid proliferation. Nuclear to cytoplasmic shifts in tumor-promoting proteins can lead to worse patient outcomes, providing opportunities to target cancer-specific processes. Herein, we review the significance of dysregulated protein localization with a focus on skin cancer. Altered localization of signaling proteins controlling cell cycle progression or cell death is a common feature of cancer. In some instances, aberrant subcellular localization results in an acquired prosurvival function. Taking advantage of this knowledge reveals novel targets useful in the development of cancer therapeutics.

AB - Aberrant subcellular localization of signaling proteins can provide cancer cells with advantages such as resistance to apoptotic cell death, increased invasiveness and more rapid proliferation. Nuclear to cytoplasmic shifts in tumor-promoting proteins can lead to worse patient outcomes, providing opportunities to target cancer-specific processes. Herein, we review the significance of dysregulated protein localization with a focus on skin cancer. Altered localization of signaling proteins controlling cell cycle progression or cell death is a common feature of cancer. In some instances, aberrant subcellular localization results in an acquired prosurvival function. Taking advantage of this knowledge reveals novel targets useful in the development of cancer therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=85070919285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070919285&partnerID=8YFLogxK

U2 - 10.1002/mc.23036

DO - 10.1002/mc.23036

M3 - Article

VL - 58

SP - 1631

EP - 1639

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 9

ER -